I could be wrong but my impression was that they have sufficient to cover the full trial process. They actually received more than the intended placement amount and also received the bonus $5mill from Europe so they are in a strong position to get on with the job. The money is there to cover the cost. What I as a shareholder require/hope is that the trials prove sufficiently successful to warrant commercialisation with FDA approval. At that point more funds would be needed. Thats probably some two years away but dont take my word for it lol.
cheers
right mix of assets to excel in cell therapies, page-25
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
-0.005(1.23%) |
Mkt cap ! $581.0M | |||
| Open | High | Low | Value | Volume |
| 41.0¢ | 41.5¢ | 39.5¢ | $1.576M | 3.906M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2506 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 8079 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |